Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5626-5635
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5626
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5626
Table 5 Distribution of three different risk factors in each score group
BMI < 18.5 or > 23.9 | Vascular invasion | Cardia cancer | |
All | 149 | 54 | 105 |
Score 0 group | 0 | 0 | 0 |
Score 1 group | 92 | 15 | 45 |
Score 2 group | 51 | 33 | 54 |
Score 3 group | 6 | 6 | 6 |
- Citation: Xu Q, Kang WZ, Xiong JP, Shao XX, Li WK, Hu HT, Tian YT. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy. World J Gastroenterol 2022; 28(38): 5626-5635
- URL: https://www.wjgnet.com/1007-9327/full/v28/i38/5626.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i38.5626